SOUTH AFRICA

Herbivac® LS

REG. NO.: G3955 (Act 36/1947)

Registration holder: Deltamune (Pty) Ltd. Marketed and distributed by Zoetis (Pty) Ltd.

Expand All
  • Each 2 ml cattle dose contains at least 102,5 TCID50 of live attenuated lumpy skin disease virus.

  • Lyophilised, live attenuated virus (modified Neethling type) for the preventive immunisation of healthy cattle against lumpy skin disease.

    • Directions for use: Use only as directed
    • The active ingredient of the vaccine is in the form of a freeze-dried pellet in a small bottle.  Use a sterile syringe to transfer approximately 5 ml of the sterile diluent to the bottle containing the freeze-dried vaccine.
    • Mix until the entire pellet has been dissolved and then transfer this suspension back to the sterile diluent.  Mix well by means of the sterile syringe.  The vaccine is now ready for use.
    • Protect the reconstituted vaccine from exposure to direct sunlight and use it without delay.
    • Dosage:   2 ml subcutaneously, preferably on the side of the neck in front of the shoulder. 
    • Immunity starts to develop about 10 days after vaccination and animals should be fully protected after 3 weeks.  However, the vaccine may not necessarily confer absolute immunity in all animals.
    • A booster dose should be given annually.
    • Vaccinate healthy animals only.
    • Vaccinated cattle should not be slaughtered for human consumption within 7 days of vaccination.
    • A temporary drop in milk production may occur within 2 weeks of vaccination.
    • Some cattle may develop a large swelling at the site of inoculation from about the fifth day onwards.  These swellings usually disappear within three weeks or remain as a small hard subcutaneous nodule.  Potential show animals could be vaccinated in the dewlap where a small scar will not be noticeable.
    • A low percentage of cattle may develop multiple superficial nodules in the skin within 7 to 12 days after vaccination.  These animals usually retain a normal habitus and appetite.  The skin lesions normally heal uneventfully over a period of 4 to 6 weeks.
    • Keep out of reach of children, uninformed persons and animals.
    • Store and handle the vaccine as prescribed.
    • Although this product has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons.  If this is suspected, seek veterinary advice and notify the registration holder.
  • Store in a refrigerator at 4 °C – 8 °C. Avoid freezing.

  • Available in 50 dose freeze dry ampules which must be reconstituted with 100 ml of sterile vaccine diluent respectively, just before use.

DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.

Ordering Products

Fax no. for Orders:
+27 21 427 6442
 
Email address for Orders:
ZoetisOrders@zoetis.com
 
Physical Address:
Zoetis South Africa (Pty) Ltd.
Co. Reg. No.: 2012/001825/07
6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196.
 
Tel:
+27 11 245 3300 or 0860 ZOETIS (0860 963847)

Terms of sale

Postal Address

Zoetis South Africa (Pty) Ltd
PostNet Suite 53
Private Bag 9976
Sandton
2146